Search ARM

Propel is a disruptive Contract Development and Manufacturing Organization focused on a new paradigm in early-stage drug development pathway to Clinical Trials
Our proprietary pre-packaged Process de-risks cell therapy translation from academic proof of concept to manufacturing readiness and clinical trial success in a cost-effective timely manner not available today.

Contact Propel BioSciences
Visit Website